England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal

A breast cancer drug from AstraZeneca will now be available in England after a pricing deal was reached, in part a result of the U.S.-U.K. pharma pact…

Continue in Briflio to read, react, comment, and share.